First-in-Human Randomized Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the KDM1A Inhibitor Vafidemstat
首次人体随机试验评估 KDM1A 抑制剂 Vafidemstat 的安全性、耐受性、药代动力学和药效学
期刊:CNS Drugs
影响因子:7.4
doi:10.1007/s40263-021-00797-x
Rosa María Antonijoan, Juan Manuel Ferrero-Cafiero, Jimena Coimbra, Montse Puntes, Joan Martínez-Colomer, María Isabel Arévalo, Cristina Mascaró, Cesar Molinero, Carlos Buesa, Tamara Maes
